The first carbon emission free pre-filled autoinjector
The increasing adoption of pre-filled self-injection systems has put the drug delivery device industry at the forefront of one of the world’s greatest challenges: the use of plastics and its impact on the environment. We need to act now and send a clear signal that we are taking our responsibility seriously.
YpsoMate Zero – The pre-filled autoinjector with net zero carbon emission First step towards achieving net zero carbon emissions by 2030
YpsoMate Zero transforms the proven YpsoMate autoinjector into a zero carbon emission device platform:
- Use of alternative materials
- Optimisation along the supply chain
- Offsetting the remaining carbon emissions
YpsoMate Zero is a zero carbon emission autoinjector offering without compromising on usability and patient safety:
- Based on the proven YpsoMate autoinjector platform
- Enabling a carbon neutral combination product
Self-medication and sustainability: Turning the vicious cycle into a virtuous one
A life cycle assessment was conducted to obtain a quantitative and systematic perspective on the environmental costs of the two-step autoinjector over its entire life cycle, including raw materials, manufacturing, and final disposal.
The life cycle analysis provides the basis for reducing the YpsoMate carbon emissions as it directs the engineering efforts toward the most pressing environmental hot spots:
- Use of alternative polymers for selected device components and packaging
- Close the loop for the packaging of device components and device sub-assemblies
- Implement design for recycling into the development process
Introduction to the YpsoMate autoinjector value chain
The life cycle analysis highlights the environmental hot spots and enables evidence-based and data-driven design optimisations. The areas subject to optimisation are highlighted in blue.
Life cycle analysis to assess the total carbon emission of the YpsoMate autoinjector
An overview of the life cycle analysis to highlight the environmental hot spots and to enable data-driven design optimisations.
Transforming the proven autoinjector into a zero carbon emission device platform
The use of alternative materials and optimization loops along the value chain have resulted in a substantial reduction of the total carbon emission. Ypsomed's Ahueni reforestation programme that commits to the highest industry standards is used to offset the remaining carbon footprint.
YpsoMate Zero at a glance
The use of alternative materials, optimisations along the value chain, and offsetting the remaining carbon footprint result in a carbon emission free pre-filled autoinjector without compromising on usability and patient safety.
Ahueni programme to offset the remaining carbon footprint
The word “Ahueni” is Swahili and means recreation, but can also be translated as new creation or regeneration. The term reflects our intentions in the Masai Mara region of Kenya: The regeneration of nature and wildlife.
Ten million trees
With the Ahueni programme, we have committed ourselves to planting at least one million trees in the Masai Mara region over the next ten years. The main objective of the Ahueni programme is to reduce global CO2 emissions. In addition, Kenya urgently needs reforestation. The local tree population is at a record low of around 7%. This circumstance is due to short-sighted use of land in recent decades.
Ahueni – facts and figures
- Foundation of our Ahueni initiative in 2017: The million trees program
- Investing in reforestation in the Masai Mara in Kenya in order to offset remaining carbon footprint which cannot be substituted
- Plan to audit and accredit the program under UNFCCC1 guidelines through an independent quality standard such as VERRA2 by mid-2022
1 United Nations Framework Convention on Climate Change
2 Verra is running the VCS program, the world’s leading voluntary program for the certification of greenhouse gas (GHG) emission reduction projects
Net zero carbon emissions by 2030
Sustainability is one of Ypsomed's strategic pillars. The company is committed to achieve net zero carbon emissions by 2030. Therefore, Ypsomed seeks to drive circular product design that minimises the environmental impact of self-medication along the entire value chain. The YpsoMate Zero is the first step towards reaching this goal. The product shows how the company assumes its social and societal responsibility and it underscores the ambition to pioneer the development of sustainable self-injection device technologies.
Join our journey to zero
The world’s first carbon emission-free autoinjector paves the way toward carbon neutral combination products. On the one hand, the insights gained from YpsoMate Zero inform the overall transition to zero carbon emission self-injection device platforms at Ypsomed. On the other hand, the YpsoMate Zero also reiterates the need to bring together the commitments of partners to achieve a net zero carbon emission combination product.
Enabling the launch of a zero carbon footprint combination product by 2030 requires the involvement and coordination of multiple actors along the value chain in order to adopt the principles of the circular economy and remove its barriers to adoption.
The journey to zero goes beyond our own operations, products, and services. To this end, we are fostering collaborative problem solving, shaping regulatory frameworks, and promoting the circular mindset with a science based approach. Collaboration along the value chain will help us to enable a zero carbon footprint combination product.
Join our journey to zero.
Get in touch with us to join our journey to zero: